Anavex Life Sciences Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +86.4% | +122.0% | +82.1% | +12.1% | -69.0% | +33.3% | +29.6% | +25.8% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -51.8% | -5.2% | +65.3% | -76.3% | +231.7% | -36.4% | +156.1% | +209.8% | -18.3% | +33.4% | +16.6% | -24.2% | +68.8% | +123.3% | -10.9% | -42.3% | +22.4% | |
| – | – | – | – | – | – | – | – | – | – | +319.7% | -65.7% | +128.2% | -16.3% | +35.9% | +14.5% | -22.8% | +68.8% | +123.3% | -6.3% | – | – | |
| – | +481.0% | -163.7% | – | +1.2% | -100.0% | – | +161.7% | +94.2% | -79.7% | -172.2% | – | -48.3% | -40.2% | -321.2% | – | -91.0% | -705.9% | – | -53.3% | +9.9% | -253.2% | |
| – | – | – | – | – | +14.5% | +167.2% | -100.0% | – | – | – | -100.0% | – | -100.0% | – | – | – | +0.0% | +0.0% | -100.0% | – | – | |
| – | – | – | – | – | +14.5% | +167.2% | – | – | – | – | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -54.1% | +3,252.8% | -74.3% | +761.0% | -70.0% | +118.2% | +59.0% | +440.5% | -86.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +3,584.5% | -101.0% | -60.6% | – | – | -50.6% | – | – | – | – | – | – | |
| – | -15.2% | +28.8% | +615.8% | +692.8% | +26.6% | +43.6% | -18.6% | -57.2% | -29.2% | +762.0% | +27.9% | -74.4% | +770.5% | -70.4% | +120.3% | +59.4% | +440.5% | -86.1% | +39.3% | -59.6% | -21.2% | |
| – | -196.5% | – | -208.4% | – | +5,342.8% | -125.0% | – | – | – | +1,972.8% | +16.1% | -176.0% | – | -124.7% | – | – | +1,639.4% | -102.4% | – | -1,109.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.